Ligand Pharmaceuticals Statistics
Total Valuation
Hamilton Lane has a market cap or net worth of $8.68 billion. The enterprise value is $8.78 billion.
Important Dates
The last earnings date was Tuesday, August 5, 2025, before market open.
| Earnings Date | Aug 5, 2025 |
| Ex-Dividend Date | Sep 19, 2025 |
Share Statistics
Hamilton Lane has 56.16 million shares outstanding. The number of shares has decreased by -19.20% in one year.
| Current Share Class | 43.50M |
| Shares Outstanding | 56.16M |
| Shares Change (YoY) | -19.20% |
| Shares Change (QoQ) | +2.39% |
| Owned by Insiders (%) | 4.69% |
| Owned by Institutions (%) | 99.25% |
| Float | 37.13M |
Valuation Ratios
The trailing PE ratio is 29.62 and the forward PE ratio is 30.27.
| PE Ratio | 29.62 |
| Forward PE | 30.27 |
| PS Ratio | 9.01 |
| Forward PS | 11.73 |
| PB Ratio | 8.86 |
| P/TBV Ratio | 11.44 |
| P/FCF Ratio | 25.68 |
| P/OCF Ratio | 24.80 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 28.02, with an EV/FCF ratio of 25.98.
| EV / Earnings | 41.38 |
| EV / Sales | 12.69 |
| EV / EBITDA | 28.02 |
| EV / EBIT | 28.89 |
| EV / FCF | 25.98 |
Financial Position
The company has a current ratio of 3.92, with a Debt / Equity ratio of 0.37.
| Current Ratio | 3.92 |
| Quick Ratio | 3.78 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 1.13 |
| Debt / FCF | 1.08 |
| Interest Coverage | 21.34 |
Financial Efficiency
Return on equity (ROE) is 35.08% and return on invested capital (ROIC) is 15.92%.
| Return on Equity (ROE) | 35.08% |
| Return on Assets (ROA) | 11.97% |
| Return on Invested Capital (ROIC) | 15.92% |
| Return on Capital Employed (ROCE) | 18.04% |
| Revenue Per Employee | $910,776 |
| Profits Per Employee | $279,208 |
| Employee Count | 760 |
| Asset Turnover | 0.44 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Hamilton Lane has paid $47.20 million in taxes.
| Income Tax | 47.20M |
| Effective Tax Rate | 13.45% |
Stock Price Statistics
The stock price has increased by +17.40% in the last 52 weeks. The beta is 1.24, so Hamilton Lane's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | +17.40% |
| 50-Day Moving Average | 149.02 |
| 200-Day Moving Average | 158.56 |
| Relative Strength Index (RSI) | 53.10 |
| Average Volume (20 Days) | 405,942 |
Short Selling Information
The latest short interest is 2.42 million, so 4.31% of the outstanding shares have been sold short.
| Short Interest | 2.42M |
| Short Previous Month | 2.36M |
| Short % of Shares Out | 4.31% |
| Short % of Float | 6.52% |
| Short Ratio (days to cover) | 2.81 |
Income Statement
In the last 12 months, Hamilton Lane had revenue of $692.19 million and earned $212.20 million in profits. Earnings per share was $5.22.
| Revenue | 692.19M |
| Gross Profit | 426.57M |
| Operating Income | 303.92M |
| Pretax Income | 226.57M |
| Net Income | 212.20M |
| EBITDA | 313.42M |
| EBIT | 303.92M |
| Earnings Per Share (EPS) | $5.22 |
Full Income StatementBalance Sheet
The company has $263.35 million in cash and $365.49 million in debt, giving a net cash position of -$102.15 million or -$1.82 per share.
| Cash & Cash Equivalents | 263.35M |
| Total Debt | 365.49M |
| Net Cash | -102.15M |
| Net Cash Per Share | -$1.82 |
| Equity (Book Value) | 995.05M |
| Book Value Per Share | 17.44 |
| Working Capital | 341.45M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $350.01 million and capital expenditures -$11.99 million, giving a free cash flow of $338.02 million.
| Operating Cash Flow | 350.01M |
| Capital Expenditures | -11.99M |
| Free Cash Flow | 338.02M |
| FCF Per Share | $6.02 |
Full Cash Flow StatementMargins
Gross margin is 61.63%, with operating and profit margins of 43.91% and 30.66%.
| Gross Margin | 61.63% |
| Operating Margin | 43.91% |
| Pretax Margin | 50.70% |
| Profit Margin | 30.66% |
| EBITDA Margin | 45.28% |
| EBIT Margin | 43.91% |
| FCF Margin | 48.83% |
Dividends & Yields
This stock pays an annual dividend of $2.16, which amounts to a dividend yield of 1.40%.
| Dividend Per Share | $2.16 |
| Dividend Yield | 1.40% |
| Dividend Growth (YoY) | 10.16% |
| Years of Dividend Growth | 8 |
| Payout Ratio | 39.48% |
| Buyback Yield | 19.20% |
| Shareholder Yield | 20.60% |
| Earnings Yield | 2.44% |
| FCF Yield | 3.89% |
Dividend DetailsAnalyst Forecast
The average price target for Hamilton Lane is $160.43, which is 3.81% higher than the current price. The consensus rating is "Hold".
| Price Target | $160.43 |
| Price Target Difference | 3.81% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
